ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-11.5x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1912.99% |
| Q3 2025 | -127.70% |
| Q2 2025 | -65.25% |
| Q1 2025 | 177.78% |
| Q4 2024 | 167.05% |
| Q3 2024 | 57.05% |
| Q2 2024 | -253.98% |
| Q1 2024 | 62.33% |
| Q4 2023 | -25.00% |
| Q3 2023 | 33.33% |
| Q2 2023 | 40.00% |
| Q1 2023 | -36.36% |
| Q4 2022 | -160.05% |
| Q3 2022 | 6.00% |
| Q2 2022 | -195.34% |
| Q1 2022 | 873.20% |
| Q4 2021 | -51.50% |
| Q3 2021 | 0.00% |
| Q2 2021 | 132.73% |
| Q1 2021 | -303.67% |
| Q4 2020 | 166.96% |
| Q3 2020 | 59.27% |
| Q2 2020 | -547.06% |
| Q1 2020 | 70.33% |
| Q4 2019 | 18.14% |
| Q3 2019 | 22.22% |
| Q2 2019 | -400.00% |
| Q1 2019 | 115.79% |
| Q4 2018 | -316.67% |
| Q3 2018 | 69.60% |
| Q2 2018 | -271.29% |
| Q1 2018 | -3.86% |
| Q4 2017 | 44.43% |
| Q3 2017 | -55.56% |
| Q2 2017 | -137.50% |
| Q1 2017 | 1835.48% |
| Q4 2016 | -38.00% |
| Q3 2016 | 554.55% |
| Q2 2016 | -101.83% |
| Q1 2016 | 59.36% |